OVRAL-28 Drug Patent Profile
✉ Email this page to a colleague
When do Ovral-28 patents expire, and what generic alternatives are available?
Ovral-28 is a drug marketed by Wyeth Pharms and is included in one NDA.
The generic ingredient in OVRAL-28 is ethinyl estradiol; norgestrel. There are twenty-six drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; norgestrel profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for OVRAL-28?
- What are the global sales for OVRAL-28?
- What is Average Wholesale Price for OVRAL-28?
Summary for OVRAL-28
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 5 |
Formulation / Manufacturing: | see details |
DailyMed Link: | OVRAL-28 at DailyMed |
![OVRAL-28 drug patent expirations Drug patent expirations by year for OVRAL-28](/p/graph/s/t/OVRAL-28-patent-expirations.png)
US Patents and Regulatory Information for OVRAL-28
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Wyeth Pharms | OVRAL-28 | ethinyl estradiol; norgestrel | TABLET;ORAL-28 | 016806-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for OVRAL-28
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Wyeth Pharms | OVRAL-28 | ethinyl estradiol; norgestrel | TABLET;ORAL-28 | 016806-001 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
Wyeth Pharms | OVRAL-28 | ethinyl estradiol; norgestrel | TABLET;ORAL-28 | 016806-001 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
Wyeth Pharms | OVRAL-28 | ethinyl estradiol; norgestrel | TABLET;ORAL-28 | 016806-001 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for OVRAL-28
See the table below for patents covering OVRAL-28 around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Denmark | 103939 | ⤷ Sign Up | |
Cyprus | 658 | Pharmaceutical compositions | ⤷ Sign Up |
Germany | 1468643 | Verfahren zur Herstellung von 2-(1'-Tetralyliden-aethyl)-2-alkyl-cyclopentan-1,3-dionen | ⤷ Sign Up |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for OVRAL-28
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
0398460 | C300221 | Netherlands | ⤷ Sign Up | PRODUCT NAME: DROSPIRENON EN ETHINYLESTRADIOL; REGISTRATION NO/DATE: RVG 23827 20000307 |
1453521 | 39/2015 | Austria | ⤷ Sign Up | PRODUCT NAME: ETHINYLESTRADIOL UND EINE KOMBINATION VON LEVONORGESTREL UND ETHINYLESTRADIOL; NAT. REGISTRATION NO/DATE: 136021 20150224; FIRST REGISTRATION: SK 17/0017/15-S 20150211 |
0771217 | 07C0001 | France | ⤷ Sign Up | PRODUCT NAME: ETHINYLESTRADIOL BETADEX CLATHRATE; NAT. REGISTRATION NO/DATE: NL 32343 20060710; FIRST REGISTRATION: NL - RVG 31781 20050804 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |